Introducing Annette Toledano, a pioneering brand dedicated to revolutionizing pain management and improving the lives of individuals worldwide. Led by Dr. Annette Toledano, a highly experienced and board-certified internist, this clinical-stage pharmaceutical company is focused on developing a powerful solution for the treatment of acute migraine and co-occurring anxiety.

Annette Toledano's flagship product is the naltrexone-acetaminophen combination—a groundbreaking medication that shows immense potential in combating neuropathic pain, including conditions like back pain, migraines, postherpetic neuralgia, and trigeminal neuralgia. Unlike traditional opioid-based treatments, which have limited effectiveness and carry the risk of addiction, the naltrexone-acetaminophen combination offers a more promising alternative. The brand's dedication to research and innovation is evident through their completion of four investigator-initiated clinical trials, displaying excellent results for various pain conditions.

Currently, Annette Toledano is launching a phase-2 clinical study specifically targeting acute migraines. With their cutting-edge approach and commitment to patient well-being, Annette Toledano is paving the way for a future without pain—one patient at a time. Contact them today to learn more about their groundbreaking solutions for pain management